Psychotropic combination in schizophrenia

European Journal of Clinical Pharmacology

Volumn 61, Issue 11, 2005, Pages 855-861

  Acquaviva, E ^a   Gasquet, I ^a   Falissard, B ^a  

^a Cochin Hospital ^*  (France)

Author keywords

Antipsychotics; Pharmaco epidemiology; Schizophrenia

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZAMIDE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; CYAMEMAZINE; DROPERIDOL; FLUPENTIXOL; HALOPERIDOL; LEVOMEPROMAZINE; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PENFLURIDOL; PERICIAZINE; PHENOTHIAZINE; PHENOTHIAZINE DERIVATIVE; PIMOZIDE; PIPAMPERONE; PIPOTIAZINE; PSYCHOTROPIC AGENT; RISPERIDONE; SULPIRIDE; SULTOPRIDE; THIORIDAZINE; TIAPRIDE; UNINDEXED DRUG; ZUCLOPENTHIXOL;

ADULT; ARTICLE; DRUG ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEDATION; STATISTICAL MODEL;

ADULT; ANTI-ANXIETY AGENTS; ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; SCHIZOPHRENIA;

EID: 28344436551     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0034-6     Document Type: Article

References (29)

1. Clark EC, Stephen JB, Ellman TA, Peacock JP (2002) Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophr Bull 28:75-82
2. Magliano L, Fiorillo A, Guarneri M, Marasco C, De Rosa C, Malangone C, Maj M, The National Mental Health Project Working Group (2004) Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey. Eur J Clin Pharmacol 60:513-522
3. Brunot A, Lachaux B, Sontag H, Casadebaig F, Philippe A, Rouillon F, Cléry-Melin P, Herguetal T, Llorca PM, Moreau-Defarges T, Guillon P, Lebrun T (2002) Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: patient characteristics, antipsychotic treatment, and care management for schizophrenia (in French). Encephale 28:129-138
4. Voruganti L, Cortese L, Owyeumi L, Kotteda V, Cernovsky Z (2002) Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study. Schizophr Res 57:201-208
5. Frangou S, Lewis M (2000) Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service. Eur Psychiatry 15:220-226
6. Fourrier A, Gasquet I, Allicar MP, Bouhassira M, Lepine JP (2000) Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists. Br J Clin Pharmacol 49:80-86
7. Frangou S, Lewis M (2000) Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service. Eur Psychiatry 15:220-226
8. Ungvari GS, Chow LY, Chiu FK (1997) Modifying psychotropic drug prescription patterns: a follow-up survey. Psychiatry Clin Neurosci 51:309-314
9. Baldessarini RJ, Kando JC, Centorrino F (1995) Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay. Am J Psychiatry 152:1038-1044
10. Zito JM, Craig TJ, Wanderling J, Siegel C (1987) Pharmacoepidemiology in 136 hospitalized schizophrenic patients. Am J Psychiatry 144:778-782
11. ANAES (1994) Stratégies thérapteutiques à long terme dans les psychoses schizophréniques. Conférence de consensus Paris
12. Lader M (1999) Some adverse effects of antipsychotics: prevention and treatment. J Clin Psychiatry 12:39-42
13. Buchanan R, Kreyenbuhl A, Zito M, Lehman A (2002) Relationship of the use of adjunctive pharmacological agents to symptoms and level of function in schizophrenia. Am J Psychiatry 159:1035-1043
14. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychological Association, Washington
15. Agresti A (1990) Categorical data analysis. Wiley Interscience, New York
16. Stokes ME, Davis CS, Koch GG (2003) Categorial data analysis using the SAS system. Wiley Interscience, New York
17. Falissard B (1998) Comprendre et utiliser les statistiques dans les sciences de la vie. Masson, Paris
18. Littel RC, Milliken GA, Stroup WW (1998) SAS system for mixed models. SAS Institute, Cary, NC
19. Brown H, Prescott R (1999) Applied mixed models in medicine. Wiley Interscience, New York
20. Nicolas G, Duret M (1998) Rapport sur l'évaluation entre les besoins hospitaliers et les effectifs en anesthésie réanimation, gynécologie obstétrique, psychiatrie et radiologie
21. Gilbody S, Wahlbeck K, Adams C (2002) Randomised trials in schizophrenia: a critical perspective of the literature. Acta Psychiatr Scand 105:243-251
22. Whitehead C, Moss S, Cardno A, Lewis G (2002) Antidepressants for people with both schizophrenia and depression. Cochrane Database Syst Rev (2):CD002305
23. Wolkowitz O, Pickard D (1991) Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. Am J Psychiatry 148:714-726
24. Leucht S, Wahlbeck K, Hamann J, Kissing W (2003) New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 361:1581-1589
25. Davis JM, Chen N, Glick ID (2003) A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60:553-564
26. Ghaemi SN, Cherry EL, Katzow JA, Goodwin FK (2000) Does olanzapine have antidepressant properties? A retrospective preliminary study. Bipolar Disord 2:196-199
27. Sajatovic M, Mullen JA, Sweitzer DE (2000) Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis. J Clin Psychiatry 63:1156-1163
28. Peuskens J, Moller HJ, Puech A (2002) Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone. Eur Neuropsychopharmacol 12:305-310
29. Parepally H, Chakravorty S, Levine J (2002) The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents. A naturalistic study at a state psychiatric hospital. Prog Neuropsychopharmacol Biol Psychiatry 26:437-440